Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: Trend analysis

BMJ

Volumn 320, Issue 7229, 2000, Pages 213-216

  Reacher, Mark H ^a   Shah, Anita ^a   Livermore, David M ^b   Wale, Martin C J ^c   Graham, Catriona ^a   Johnson, Alan P ^b   Heine, Hilary ^a   Monnickendam, Marjorie A ^a   Barker, Keith F ^d   James, Dorothy ^b   George, Robert C ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

^c QUEEN S MEDICAL CENTRE   (United Kingdom)

^d International Medical Department   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ERYTHROMYCIN; GENTAMICIN; METICILLIN; PENICILLIN G; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; REGRESSION ANALYSIS; STREPTOCOCCUS PNEUMONIAE; UNITED KINGDOM;

BACTEREMIA; DRUG RESISTANCE, MICROBIAL; ENGLAND; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE; WALES;

EID: 0034700926     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.320.7229.213     Document Type: Article

References (24)

1. Young LS. Sepsis syndrome. In: Mandell GL,Bennett JE,Dolin R, eds. Principles and practice of infectious diseases. New York: Churchill Livingstone, 1995: 690–705.
2. Livermore D, MacGowan AP, Wale MCJ. Surveillance of antimicrobial resistance. BMJ 1998; 317: 614–615.
3. House of Lords Select Committee on Science and Technology. Resistance to antibiotics and other antimicrobial agents. London: Stationery Office, 1998.
4. Standing Medical Advisory Committee: Subgroup on Antimicrobial Resistance. The path of least resistance. London: Department of Health, 1998.
5. Wise R, Hart T, Cars O, Streulens M, Helmuth R, Huovinen P, et al. Antimicrobial resistance is a major threat to public health. BMJ 1998; 317: 609–610.
6. Duckworth G, Cookson B, Humphreys H, Heathcock R. Working party report: revised guidelines for the control of methicillin-resistant Staphylococcus aureus infection in hospitals. J Hosp Infect 1998; 39: 253–290.
7. Hospital Infection Working Group of the Department of Health and the Public Health Laboratory Service. Hospital infection control: guidance on the control of infection in hospitals. London: Department of Health, 1995.
8. Grant AD, Eke E. Application of information technology to the laboratory reporting of communicable disease in England and Wales. Commun Dis Rep CDR Rev 1993; 3: R75–R78.
9. Henry R. CoSurv: A regional computing strategy for communicable disease surveillance. PHLS Microbiol Digest 1996; 13: 26–28.
10. Speller DCE, Johnson AP, James D, Marples RR, Charlett A, George RC. Resistance to methicillin and other antibiotics in isolates of Staphylococcus aureus from blood and cerebrospinal fluid, England and Wales, 1989-95. Lancet 1997; 350: 323–325.
11. Johnson AP, James D, Livermore DM. Increasing prevalence of methicillin-resistance amongst Staphylococcus aureus blood culture isolates. J Antimicrob Chemother 1999; 43: 160.
12. Laurichesse H, Grimaud O, Waight P, Johnson AP, George RC, Miller E. Pneumococcal bacteraemia and meningitis in England and Wales, 1993 to 1995. Commun Dis Publ Hlth 1998; 1: 22–27.
13. Livermore DM, Threlfall EJ, Reacher MH, Johnson AP, James D, Cheasty T, et al. Are routine sensitivity test data suitable for the surveillance of resistance? Resistance rates amongst Escherichia coli from blood and CSF from 1991-97 as assessed by routine and centralised testing. J Antimicrob Chemother (in press).
14. Anonymous. AMM directory: medical microbiology services in the United Kingdom and the Republic of Ireland. St Leonards on Sea: Association of Medical Microbiologists, 1998: 139–143.
15. Anonymous. Look inside: the presentation of bacteraemia data in the CDR weekly has changed. Commun Dis Report CDR Wkly 1997; 7: 13.
16. Clayton D, Hills M. Poisson and logistic regression. In: Statistical models in epidemiology. Oxford: Oxford University Press, 1993: 227–236.
17. Bannerjee SN, Emori TG, Culver DH, Gaynes RP, Jarvis WR, Horan T, et al. Secular trends in nosocomial bloodstream infections in the United States. Am J Med 1991; 91 (suppl 3B):86–9S.
18. Pittet D, Wenzel RP. Nosocomial bloodstream infections. Arch Int Med 1995; 155: 1177–1184.
19. Cockerill FR, Hughes JG, Vetter EA, Mueller RA, Weaver AL, Ilstrup DM, et al. Analysis of 281,797 consecutive blood cultures performed over an eight-year period: trends in micro-organisms isolated and the value of anaerobic culture of blood. Clin Infect Dis 1997; 24: 403–418.
20. Johnson AP. Antibiotic resistance among clinically important Gram positive bacteria in the UK. J Hosp Infect 1998; 40: 17–26.
21. Hargreaves RM, Slack MPE, Howard AJ, Anderson E, Ramsay ME. Changing patterns of invasive Haemophilus influenzae disease in England and Wales after introduction of the Hib vaccination programme. BMJ 1996; 312: 160–161.
22. Anonymous. Staphylococcus aureus bacteraemia: England and Wales, January to March 1999. Commun Dis Rep CDR Wkly 1999; 9: 185.
23. Anonymous. Nosocomial infection national surveillance scheme. Commun Dis Report CDR Wkly 1996; 6: 83.
24. Anonymous. National nosocomial infections surveillance (NNIS) system report, data summary from October 1986-April 1998, issued June 1998. Am J Infect Control 1998; 26: 522–533.